Business Description
Avecho Biotechnology Ltd
ISIN : AU0000047441
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 31.45 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -45.57 | |||||
Beneish M-Score | -6.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.61 | |||||
9-Day RSI | 46.09 | |||||
14-Day RSI | 46.92 | |||||
6-1 Month Momentum % | -14.29 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.31 | |||||
Quick Ratio | 8.19 | |||||
Cash Ratio | 6.53 | |||||
Days Inventory | 149.44 | |||||
Days Sales Outstanding | 324.49 | |||||
Days Payable | 322.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.6 | |||||
Shareholder Yield % | -77.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -9.3 | |||||
Operating Margin % | -1008.03 | |||||
Net Margin % | -726.64 | |||||
FCF Margin % | -672.3 | |||||
ROE % | -93.75 | |||||
ROA % | -70.69 | |||||
ROIC % | -346.26 | |||||
ROC (Joel Greenblatt) % | -874.19 | |||||
ROCE % | -89.96 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.5 | |||||
EV-to-EBIT | -1.22 | |||||
EV-to-EBITDA | -1.29 | |||||
EV-to-Revenue | 8.84 | |||||
EV-to-FCF | -1.31 | |||||
Earnings Yield (Greenblatt) % | -81.97 | |||||
FCF Yield % | -33.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avecho Biotechnology Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.473 | ||
EPS (TTM) (A$) | -0.001 | ||
Beta | 1.25 | ||
Volatility % | 101.72 | ||
14-Day RSI | 46.92 | ||
14-Day ATR (A$) | 0.000761 | ||
20-Day SMA (A$) | 0.0034 | ||
12-1 Month Momentum % | -50 | ||
52-Week Range (A$) | 0.003 - 0.009 | ||
Shares Outstanding (Mil) | 3,169.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avecho Biotechnology Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avecho Biotechnology Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Avecho Biotechnology Ltd Frequently Asked Questions
What is Avecho Biotechnology Ltd(ASX:AVE)'s stock price today?
When is next earnings date of Avecho Biotechnology Ltd(ASX:AVE)?
Does Avecho Biotechnology Ltd(ASX:AVE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |